• Report on the state of the art in cellular therapy and blood and marrow transplantation.
• Analyze new methods and controversial issues in clinical management strategies for reducing toxicity.
• Assess new basic science information in areas of immunogenetics, molecular biology, stem cell biology, and immunology as it relates to hematopoietic stem cell transplantation in the treatment of hematologic malignancy and solid tumors.
• Review accomplishments of ASBMT, including progress on organizational, societal, and regulatory issues in blood and marrow transplantation.
• Review CIBMTR research accomplishments and set the organization’s scientific agenda for next year.
• Report on contemporary principles in BMT nursing, pharmacy, data management, clinical research analysis, and transplant center administration.